So-Young Park

doi:10.12701/jyms.2023.00269

Articles

Page Path: HOME > J Yeungnam Med Sci > Volume 40(2); 2023 > Article

Editorial Journal of Yeungnam Medical Science is now indexed in Scopus, a great step closer to a journal’s goal: So-Young Park; Journal of Yeungnam Medical Science 2023;40(2):113-114.
DOI: https://doi.org/10.12701/jyms.2023.00269
Published online: March 31, 2023

Department of Physiology, Yeungnam University College of Medicine, Daegu, Korea

Corresponding author: So-Young Park, MD, PhD Department of Physiology, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea Tel: +82-53-640-6923 • E-mail: sypark@med.yu.ac.kr

• Received: March 20, 2023 • Revised: March 23, 2023 • Accepted: March 27, 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next

2,378 Views
67 Download
1 Web of Science
3 Crossref

Full Article

Download PDF

Notes

Congratulations! Journal of Yeugnam Medical Science (JYMS) was finally accepted for indexing in Scopus. On the evening of March 11, 2023, I received a call from the managing editor of JYMS with this great news. I checked through the e-mail and verified that the Scopus Content Selection and Advisory Board (CSAB) had reviewed the application and approved JYMS for coverage. The news was too good to believe.

Now, I am delighted to share this great news with the readers, authors, and reviewers of JYMS. This achievement would not have been possible without their contributions and help. I also thank the past and present editorial board members for their dedication to JYMS.

Since the inaugural issue of JYMS in 1984, there have been milestones that greatly contributed to the acceptance of JYMS to Scopus. The chronological details of JYMS until its indexation in Scopus are presented below to help the editors of other journals understand the process (Table 1).

JYMS is currently awaiting evaluation for Emerging Sources Citation Index (ESCI) listing by Clarivate Analytics. If JYMS is accepted for ESCI, Journal Citation Reports (JCR) impact factor (IF) is very important for JYMS to be listed in Science Citation Index Expanded (SCIE). To increase the JCR IF, JYMS will try to publish high-quality articles that can be cited in SCIE-listed journals. JYMS will also recruit eminent editors from various countries to improve the quality of the journal. Our editorial team will do its best to make JYMS an internationally renowned journal.

Notes

Conflicts of interest

So-Young Park has been the editor-in-chief of Journal of Yeungnam Medical Science since 2021. Otherwise, no potential conflict of interest relevant to this article was reported.

Table 1.

The history of the Journal of Yeungnam Medical Science development

Date	Key milestones
Dec 1984	The inaugural issue was published in Korean with 15 articles, and its name was Yŏngnam Ŭidae haksulji in Korean
Jul 1994	International standard serial number was assigned (pISSN 1225-7737)
Jun 1996	The journal joined as a member of the Korean Association of Medical Journal Editors (KAMJE)
Dec 2004	The journal was indexed in KoreaMed
Mar 2012	The journal was indexed in KoreaScience
Jun 2012	The journal’s English name was added as Yeungnam University Journal of Medicine (pISSN 1225-7737, eISSN 2234-8042)
Feb 2013	The journal was indexed in KoreaMed Synapse
Jan 2014	The journal became a member of the Korean Council of Science Editors (KCSE)
Jun 2015	The journal began publishing articles online only
Jun 2015	The journal name remained the same (Yeungnam University Journal of Medicine) and a new ISSN was issued (eISSN 2384-0293)
Dec 2016	The journal was indexed as a candidate journal in Korea Citation Index (KCI)
Jun 2018	The journal adopted an English-only policy and online submission and review systems were introduced
Oct 2018	The journal was indexed as an accredited journal in KCI
Jun 2019	The journal was indexed in the Directory of Open Access Journals (DOAJ)
Oct 2019	The journal was indexed in PubMed Central (PMC) and became searchable through PubMed
Jan 2020	International-level manuscript editing was implemented through professional manuscript editing by InfoLumi (Seoul, Korea)
Oct 2020	The journal was indexed in Chemical Abstracts Service (CAS)
Jan 2022	The journal’s name was changed to Journal of Yeungnam Medical Science (eISSN 2799-8010)
Jan 2022	The journal expanded the types of articles published: imagery, image vignette, and resident fellow section were launched
Dec 2022	The journal was indexed in ScienceCentral
Mar 2023	The journal was accepted to Scopus^a)

^a)The reviewer’s comment was as follows: “This institutional English language journal from South Korea is publishing 20–30 items per annum from all health disciplines, with a substantial increase in citation activity (>600) since last reviewed. The editors have responded constructively to the previous Scopus evaluation in 2019, and on balance, there are no obvious contraindications to accession to Scopus at this point.”

Figure & Data

References

Citations

Citations to this article as recorded by

Appreciation to peer reviewers in 2023
So-Young Park
Journal of Yeungnam Medical Science.2024; 41(1): 1. CrossRef
Appreciation to peer reviewers in 2024
So-Young Park
Journal of Yeungnam Medical Science.2024; 42: 1. CrossRef
Journal of Yeungnam Medical Science is indexed in Emerging Sources Citation Index (ESCI)
So-Young Park
Journal of Yeungnam Medical Science.2023; 40(4): 317. CrossRef

PubReader
ePub Link
Cite

CITE

export Copy Format

Close

XML Download

Related articles

Journal of Yeungnam Medical Science is indexed in Emerging Sources Citation Index (ESCI)

Journal of Yeungnam Medical Science is now indexed in Scopus, a great step closer to a journal’s goal

Date	Key milestones
Dec 1984	The inaugural issue was published in Korean with 15 articles, and its name was Yŏngnam Ŭidae haksulji in Korean
Jul 1994	International standard serial number was assigned (pISSN 1225-7737)
Jun 1996	The journal joined as a member of the Korean Association of Medical Journal Editors (KAMJE)
Dec 2004	The journal was indexed in KoreaMed
Mar 2012	The journal was indexed in KoreaScience
Jun 2012	The journal’s English name was added as Yeungnam University Journal of Medicine (pISSN 1225-7737, eISSN 2234-8042)
Feb 2013	The journal was indexed in KoreaMed Synapse
Jan 2014	The journal became a member of the Korean Council of Science Editors (KCSE)
Jun 2015	The journal began publishing articles online only
Jun 2015	The journal name remained the same (Yeungnam University Journal of Medicine) and a new ISSN was issued (eISSN 2384-0293)
Dec 2016	The journal was indexed as a candidate journal in Korea Citation Index (KCI)
Jun 2018	The journal adopted an English-only policy and online submission and review systems were introduced
Oct 2018	The journal was indexed as an accredited journal in KCI
Jun 2019	The journal was indexed in the Directory of Open Access Journals (DOAJ)
Oct 2019	The journal was indexed in PubMed Central (PMC) and became searchable through PubMed
Jan 2020	International-level manuscript editing was implemented through professional manuscript editing by InfoLumi (Seoul, Korea)
Oct 2020	The journal was indexed in Chemical Abstracts Service (CAS)
Jan 2022	The journal’s name was changed to Journal of Yeungnam Medical Science (eISSN 2799-8010)
Jan 2022	The journal expanded the types of articles published: imagery, image vignette, and resident fellow section were launched
Dec 2022	The journal was indexed in ScienceCentral
Mar 2023	The journal was accepted to Scopus^a)

Table 1. The history of the Journal of Yeungnam Medical Science development

The reviewer’s comment was as follows: “This institutional English language journal from South Korea is publishing 20–30 items per annum from all health disciplines, with a substantial increase in citation activity (>600) since last reviewed. The editors have responded constructively to the previous Scopus evaluation in 2019, and on balance, there are no obvious contraindications to accession to Scopus at this point.”